tar-210 erdafitinib intravesical delivery system in non-muscle invasive bladder cancer
Published 8 months ago • 289 plays • Length 2:15Download video MP4
Download video MP3
Similar videos
-
0:56
the future of the tar-210 delivery system for erdafitinib in nmbic
-
4:51
expert video report on the management of patients with high-risk non-muscle invasive bladder cancer
-
7:16
sesaua 2024: tar-210, 200 for nmibc
-
2:21
novel treatments in muscle invasive and non-muscle invasive bladder cancer
-
1:17
exploring ctdna in muscle-invasive bladder cancer: future applications and current limitations
-
0:34
cfdna for mrd detection in non-muscle invasive bladder cancer
-
2:19
effectiveness of photodynamic assessments in non-muscle invasive bladder cancer: real-life study
-
1:27
thor-2 cohort 3 interim analysis: erdafitinib in intermediate-risk nmibc with fgfr3/2 alterations
-
5:14
erdafitinib demonstrates efficacy in intermediate-risk nmibc with fgfr alterations
-
0:55
targeted therapy option of erdafitinib in bladder cancer #oncology #cancer #2023
-
0:57
tar200 for non-muscle invasive bladder cancer, a novel approach | dr. rana mckay | oncology brothers
-
1:02
a randomized trial of photodynamic surgery in non–muscle-invasive bladder cancer
-
1:12
scott tagawa, md, on the study investigating nadofaragene firadenovec in bcg unresponsive nmibc
-
1:45
the future of non-muscular invasive bladder cancer management
-
1:08
systemic treatments for non-muscle invasive bladder cancer
-
4:28
very high risk non-muscle-invasive bladder cancer (nmibc) in the current landscape of nmibc
-
11:35
update on first biomarker-directed trial of non-muscle-invasive bladder cancer
-
3:23
intravesical chemotherapy and chemohypherthermia in non-muscle-invasive bladder cancer
-
10:46
new treatment of non-muscle-invasive bladder cancer